REDS-IV-P - CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS), PHASE 1.

Vitalant, San Francisco CA

Investigators

Abstract

Blood safety implications and advancing testing for screening donors with HIV infection taking antiretroviral (ART) and pre-exposure prophylaxis (PrEP) therapies